Haemonetics Corp. (hae 0 03/01/26)
13F holders, Q4 2024 (December 31)9holders −1
1new positions
2sold out
$0.94avg. 13F price*
At the end of Q4 2024, 9 institutions reported holding Haemonetics Corp. (hae 0 03/01/26) in their 13F filings, down 1 from Q3 2024. 1 opened new positions and 2 sold out. The largest holders were Angelo Gordon & Co., L.P. ($5.6M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($3.7M) and Toronto Dominion Bank ($2.8M).
- Company
- Haemonetics Corp. (hae 0 03/01/26)
- CUSIP
- 405024AB6
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $5.6M |
| Exits | 2 | $51K |
All 13F filers, Q3 2024 → Q4 2024: 6,010,000 shares bought and 134,000 shares sold, net +5,876,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Angelo Gordon & Co., L.P. | 1.43% | New | 6,000,000 | $5.6M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 4,000,000 | $3.7M |
| Toronto Dominion Bank | 0.01% | No change | 3,000,000 | $2.8M |
| Sei Investments Co. | 0.00% | No change | 335,000 | $315K |
| Oppenheimer Asset Management Inc. | 0.00% | Reduce -9.6% | 188,000 | $177K |
| Truist Financial Corp. | 0.00% | No change | 145,000 | $136K |
| Stephens Inc. | 0.00% | Reduce -48.1% | 56,000 | $53K |
| LPL Financial LLC | 0.00% | Reduce -14.6% | 41,000 | $38K |
| Commonwealth Equity Services, LLC | 0.00% | Add +100.0% | 20,000 | $19K |
"% of holder's portfolio" is HAEMONETICS CORP (HAE 0 03/01/26)'s weight in each manager's 13F, not the share of Haemonetics Corp. (hae 0 03/01/26) the manager owns.